New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity
- Citation:
- El‐Gazzar, Y. I., H. R. ghaiad, A. E. M. Kerdawy, R. F. George, H. H. Georgey, K. M. Youssef, and H. I. El‐Subbagh, "New quinazolinone‐based derivatives as DHFR/EGFR‐TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity", Archiv der Pharmazie, vol. 356 , pp. 2200417, 2023.